discovery laboratories inc
W. Thomas Amick
Chief Executive Officer, President and Director, Dendreon Corp.
|Age||Total Calculated Compensation||This person is connected to 35 board members in 7 different organizations across 9 different industries.|
See Board Relationships
Mr. W. Thomas Amick, also known as Tom, has been Chief Executive Officer and President of Dendreon Corp. since July 30, 2014. Mr. Amick served as the Chief Executive Officer of Discovery Laboratories Inc. from October 18, 2010 to January 4, 2013 and previously served as its Interim Chief Executive Officer from August 13, 2009 to October 18, 2010. Mr. Amick served as the Executive Chairman of Aldagen, Inc from March 2005 to February 23, 2010, Chief Executive Officer from ...
2600 Kelly RoadPhone: 215-488-9300
Warrington, Pennsylvania 18976
Board Members Memberships*
Director and Member of Compensation Committee
Former Chairman and Chief Executive Officer
Former Chief Executive Officer, President and Director
Chief Executive Officer, President and Director
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|James A. Bianco M.D.||Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee|
CTI BioPharma Corp.
|James M. Gower||Chairman, Chief Executive Officer and Member of Finance Committee|
Rigel Pharmaceuticals, Inc.
|Rajesh C. Shrotriya M.D.||Chairman, Chief Executive Officer, Chairman of Product Acquisition Committee and Chairman of Placement Committee|
Spectrum Pharmaceuticals, Inc.
|Aijaz Tobaccowalla||Managing Director, Additional Non-Executive Director, Member of Share Transfer Committee, Member of Audit Committee and Member of Shareholders' / Investors' Grievance Committee|
|Aijaz Tobaccowalla||Managing Director, Additional Director and Member of Board Administrative Committee|
|17.6M||Compensation as of Fiscal Year 2013.|